AP2002002674A0 - Clear Aqueous Anaesthetic composition. - Google Patents

Clear Aqueous Anaesthetic composition.

Info

Publication number
AP2002002674A0
AP2002002674A0 APAP/P/2002/002674A AP2002002674A AP2002002674A0 AP 2002002674 A0 AP2002002674 A0 AP 2002002674A0 AP 2002002674 A AP2002002674 A AP 2002002674A AP 2002002674 A0 AP2002002674 A0 AP 2002002674A0
Authority
AP
ARIPO
Prior art keywords
clear aqueous
propofol
compositions
composition
cyclodcxtrin
Prior art date
Application number
APAP/P/2002/002674A
Other languages
English (en)
Inventor
Mr Srikanth Annappa PAI
Ms Sangeeeta Hanurmesh Rivanka'r
Shilpa Sudhakar Kocha
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of AP2002002674A0 publication Critical patent/AP2002002674A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/2002/002674A 2000-06-21 2000-12-14 Clear Aqueous Anaesthetic composition. AP2002002674A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (forum.php) 2000-06-21 2000-06-21
PCT/IN2000/000124 WO2001097796A1 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition

Publications (1)

Publication Number Publication Date
AP2002002674A0 true AP2002002674A0 (en) 2002-12-31

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002674A AP2002002674A0 (en) 2000-06-21 2000-12-14 Clear Aqueous Anaesthetic composition.

Country Status (26)

Country Link
US (1) US7138387B2 (forum.php)
EP (1) EP1299095B1 (forum.php)
JP (1) JP4907833B2 (forum.php)
KR (1) KR100810066B1 (forum.php)
CN (1) CN1254237C (forum.php)
AP (1) AP2002002674A0 (forum.php)
AT (1) ATE267592T1 (forum.php)
AU (2) AU3597201A (forum.php)
BG (1) BG107463A (forum.php)
BR (1) BR0017268A (forum.php)
CA (1) CA2414064C (forum.php)
DE (1) DE60011149T2 (forum.php)
DK (1) DK1299095T3 (forum.php)
EA (1) EA005589B1 (forum.php)
ES (1) ES2222271T3 (forum.php)
HU (1) HUP0301646A3 (forum.php)
IL (1) IL153387A0 (forum.php)
IN (1) IN187686B (forum.php)
MX (1) MXPA02012611A (forum.php)
NO (1) NO20025999D0 (forum.php)
NZ (1) NZ523643A (forum.php)
PL (1) PL359624A1 (forum.php)
PT (1) PT1299095E (forum.php)
WO (1) WO2001097796A1 (forum.php)
YU (1) YU2703A (forum.php)
ZA (1) ZA200300336B (forum.php)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (forum.php) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
CN1329036C (zh) * 2001-12-28 2007-08-01 Mgigp公司 普鲁泊福水溶性前药的以水为基质的药物制剂
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック（プロプライエタリー）リミテッド 医薬組成物
CA2494297C (en) 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
EP1585548B1 (en) * 2002-12-09 2018-06-27 Abraxis BioScience, LLC Compositions and methods of delivery of pharmacological agents
KR20060130646A (ko) * 2004-01-14 2006-12-19 가부시키가이샤 오츠까 세이야꾸 고죠 프로포폴 함유 지방 유제
WO2006030450A2 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
CA2618799C (en) * 2005-08-12 2013-06-04 Bharat Serums & Vaccines Ltd. Aqueous anaesthetic compositions comprising propofol
WO2007128866A2 (en) * 2006-05-09 2007-11-15 Novobion Oy Novel chemical compositions
EP2269116A4 (en) * 2008-03-11 2011-09-07 3M Innovative Properties Co PHOTOGRAPHIC MASKS HAVING PROTECTIVE LAYER
WO2010148288A2 (en) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Pharmaceutical formulations with low aqueous levels of free unbound drug
EP2456823A4 (en) 2009-07-21 2012-12-26 3M Innovative Properties Co CURABLE COMPOSITION, METHOD FOR COATING A PHOTO TOOL, AND COATED PHOTO TOOL
CN102549042B (zh) 2009-09-16 2015-01-28 3M创新有限公司 氟化涂料和用其制作的底片
WO2011034847A1 (en) 2009-09-16 2011-03-24 3M Innovative Properties Company Fluorinated coating and phototools made therewith
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
EP2484350B1 (de) * 2011-02-04 2016-04-20 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung, enthaltend einen Komplex eines Propofolsalzes mit einem Cyclodextrin
IN2014KN01341A (forum.php) 2011-11-29 2015-10-16 Jurox Pty Ltd
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
AU2013305767B2 (en) 2012-08-21 2018-05-24 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
US10646439B2 (en) * 2016-01-29 2020-05-12 Cuda Anesthetics, Llc Aqueous pharmaceutical formulation comprising propofol
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
WO2001097796A1 (en) 2001-12-27
EA005589B1 (ru) 2005-04-28
US7138387B2 (en) 2006-11-21
IN187686B (forum.php) 2002-06-08
NZ523643A (en) 2004-05-28
CN1454085A (zh) 2003-11-05
DE60011149T2 (de) 2005-07-07
NO20025999L (no) 2002-12-13
CA2414064A1 (en) 2001-12-27
CA2414064C (en) 2013-01-08
EP1299095B1 (en) 2004-05-26
EA200300047A1 (ru) 2003-06-26
US20040014718A1 (en) 2004-01-22
KR100810066B1 (ko) 2008-03-05
HUP0301646A2 (hu) 2003-09-29
ZA200300336B (en) 2004-04-08
BG107463A (en) 2003-11-28
DE60011149D1 (de) 2004-07-01
YU2703A (sh) 2006-03-03
EP1299095A1 (en) 2003-04-09
KR20030023875A (ko) 2003-03-20
CN1254237C (zh) 2006-05-03
BR0017268A (pt) 2003-05-27
PT1299095E (pt) 2004-10-29
DK1299095T3 (da) 2004-10-11
HUP0301646A3 (en) 2005-06-28
AU3597201A (en) 2002-01-02
JP2003535893A (ja) 2003-12-02
NO20025999D0 (no) 2002-12-13
ES2222271T3 (es) 2005-02-01
JP4907833B2 (ja) 2012-04-04
ATE267592T1 (de) 2004-06-15
IL153387A0 (en) 2003-07-06
AU2001235972B2 (en) 2005-07-21
MXPA02012611A (es) 2004-07-30
PL359624A1 (en) 2004-08-23

Similar Documents

Publication Publication Date Title
AP2002002674A0 (en) Clear Aqueous Anaesthetic composition.
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
IL153297A0 (en) Compounds and compositions for delivering active agents
DK1157037T3 (da) GCSF-konjugater
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
SE0001899D0 (sv) New compounds
HUT75513A (en) Taxane class derivative based pharmaceutical compositions and their preparation
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
PL370111A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
AU2003273413A1 (en) Pharmaceutically active oligosaccharide conjugates
BG103969A (en) C-4"-substituted macrolide derivatives
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA03006054A (es) Composiciones de propofol claras, estables.
ES2105923B1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BE2016C017I2 (forum.php)
ES2170649B1 (es) Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
MXPA04002099A (es) Composiciones medicinales para neuropatia diabetica.
SE0002354D0 (sv) New formulation
EP3747443A3 (en) Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis